Are you Dr. Kochenderfer?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 6 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Nih
Bldg 10
Bethesda, MD 20892Phone+1 240-760-6062
Summary
- Dr. James Kochenderfer, MD is a hematologist in Bethesda, Maryland. He is currently licensed to practice medicine in Tennessee and Texas.
Education & Training
- West Virginia University School of MedicineClass of 1995
Certifications & Licensure
- TX State Medical License 1998 - 2026
- TN State Medical License 1998 - 1999
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Multi-niche human bone marrow on-a-chip for studying the interactions of adoptive CAR-T cell therapies with multiple myeloma.Delta Ghoshal, Ingrid Petersen, Rachel Ringquist, Liana Kramer, Eshant Bhatia
Biomaterials. 2025-05-01 - Chimeric antigen receptor T cell therapy for autoimmune disease.James B Chung, Jennifer N Brudno, Dominic Borie, James N Kochenderfer
Nature Reviews. Immunology. 2024-11-01 - 27 citationsCurrent understanding and management of CAR T cell-associated toxicities.Jennifer N Brudno, James N Kochenderfer
Nature Reviews. Clinical Oncology. 2024-07-01
Press Mentions
- Novel 'Off the Shelf' CAR-T Product Shows Promise in MyelomaFebruary 2nd, 2023
- CRISPR Gene-Editing May Boost Cancer Immunotherapy, New Study FindsDecember 13th, 2022
- Insurance “Roadblock” Delays Initiation of “Potentially Lifesaving” CAR-T Therapy in LymphomaDecember 20th, 2023
- Join now to see all